心脉医疗
(688016)
| 流通市值：117.73亿 | | | 总市值：117.73亿 |
| 流通股本：1.23亿 | | | 总股本：1.23亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,085,676,371.9 | 2,170,604,749.23 | 1,603,941,147.85 | 1,945,208,939.65 |
| 应收票据及应收账款 | 355,333,176.48 | 209,761,864.13 | 267,152,341.4 | 339,186,665.07 |
| 其中：应收票据 | - | - | 60,537,304.94 | - |
| 应收账款 | 355,333,176.48 | 209,761,864.13 | 206,615,036.46 | 339,186,665.07 |
| 应收款项融资 | 101,428,265.75 | 44,282,361.17 | - | - |
| 预付款项 | 33,424,319.24 | 38,199,695.39 | 38,983,289.21 | 23,900,461.62 |
| 其他应收款合计 | 2,588,206.93 | 2,076,795.17 | 3,181,393.82 | 1,155,787.35 |
| 存货 | 234,214,291.71 | 266,400,395.42 | 270,280,250.73 | 200,252,062.23 |
| 其他流动资产 | 8,437,148.7 | 8,839,331.88 | 8,622,644.22 | 6,826,455.88 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,881,101,780.71 | 2,740,165,192.39 | 3,087,632,968.6 | 3,597,267,495.09 |
| 非流动资产: | | | | |
| 长期股权投资 | - | - | - | 121,763,112.37 |
| 固定资产 | 99,371,114.47 | 100,860,832.05 | 100,476,043.27 | 99,039,112.93 |
| 在建工程 | 301,897,220.92 | 288,271,813.22 | 236,544,457.51 | 214,395,370.11 |
| 使用权资产 | 16,972,325.48 | 22,625,274 | 22,537,587.58 | 26,394,610.43 |
| 无形资产 | 427,721,227.48 | 440,245,664.17 | 414,896,183.51 | 219,658,232.95 |
| 开发支出 | 173,691,484.81 | 160,581,704.08 | 144,432,207.63 | 164,793,222.36 |
| 商誉 | 447,069,841.03 | 435,877,846.07 | 474,685,687.19 | - |
| 长期待摊费用 | 21,528,806.25 | 25,399,468.49 | 27,563,321.03 | 30,048,683.68 |
| 递延所得税资产 | 25,543,195.14 | 22,930,716.35 | 28,340,554.76 | 28,340,554.76 |
| 其他非流动资产 | 69,979,827.12 | 54,638,940.49 | 21,428,594.04 | 22,701,090.6 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,583,775,042.7 | 1,551,432,258.92 | 1,470,904,636.52 | 927,133,990.19 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 4,464,876,823.41 | 4,291,597,451.31 | 4,558,537,605.12 | 4,524,401,485.28 |
| 流动负债: | | | | |
| 短期借款 | 140,000,000 | 14,000,000 | - | - |
| 应付票据及应付账款 | 30,699,202.01 | 41,269,039.53 | 52,414,816.24 | 59,585,503.51 |
| 应付账款 | 30,699,202.01 | 41,269,039.53 | 52,414,816.24 | 59,585,503.51 |
| 合同负债 | 17,542,163.86 | 4,569,966.4 | 6,591,283.27 | 19,641,681.12 |
| 应付职工薪酬 | 49,416,227.32 | 67,647,695.65 | 49,829,061.5 | 49,378,359.3 |
| 应交税费 | 41,495,578.99 | 18,643,006.11 | 23,521,619.53 | 77,042,050.58 |
| 其他应付款合计 | 154,365,792.32 | 167,218,778.95 | 356,274,329.57 | 146,547,856.55 |
| 应付股利 | - | - | 203,382,493.05 | 768,069.08 |
| 一年内到期的非流动负债 | 12,199,407.09 | 12,890,361.4 | 11,739,104.81 | 11,819,086.05 |
| 其他流动负债 | 12,799,933.46 | 12,799,933.46 | 13,235,641.94 | 13,610,877.55 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 458,518,305.05 | 339,038,781.5 | 513,605,856.86 | 377,625,414.66 |
| 非流动负债: | | | | |
| 租赁负债 | 8,450,424.41 | 13,969,561.49 | 14,572,212.35 | 18,262,437.09 |
| 预计负债 | 7,664,300.97 | 7,654,129.69 | 8,957,119.8 | 8,571,953.3 |
| 递延收益 | 57,899,936.54 | 59,100,630.3 | 59,132,482.44 | 60,413,313.77 |
| 递延所得税负债 | 47,788,043.99 | 49,362,321.14 | 41,429,245.72 | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 121,802,705.91 | 130,086,642.62 | 124,091,060.31 | 87,247,704.16 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 580,321,010.96 | 469,125,424.12 | 637,696,917.17 | 464,873,118.82 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 123,262,116.97 | 123,262,116.97 | 123,262,117 | 123,262,117 |
| 资本公积 | 2,654,781,945.01 | 2,655,696,532.89 | 2,651,997,969.59 | 2,647,308,323.82 |
| 减:库存股 | 191,569,524.37 | 120,002,258.8 | 79,999,658.21 | - |
| 其他综合收益 | -16,967,390.76 | -13,705,026.1 | -5,555,939.95 | 1,652,241.33 |
| 盈余公积 | 61,631,058.49 | 61,631,058.49 | 61,631,058.49 | 41,363,126.5 |
| 未分配利润 | 1,214,597,510.58 | 1,084,960,612.25 | 1,136,197,916.48 | 1,210,033,834.56 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 3,845,735,715.92 | 3,791,843,035.7 | 3,887,533,463.4 | 4,023,619,643.21 |
| 少数股东权益 | 38,820,096.53 | 30,628,991.49 | 33,307,224.55 | 35,908,723.25 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 3,884,555,812.45 | 3,822,472,027.19 | 3,920,840,687.95 | 4,059,528,366.46 |
| 负债和股东权益合计 | 4,464,876,823.41 | 4,291,597,451.31 | 4,558,537,605.12 | 4,524,401,485.28 |
| 公告日期 | 2025-04-30 | 2025-03-29 | 2024-10-30 | 2024-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |